B

Bionano Genomics

BNGO

0.58760
USD
-0.0527
(-8.23%)
Market Closed
Volume
67,422
EPS
0
Div Yield
0
P/E
0
Market Cap
26,401,119
Related Instruments
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
F
FSLY
-0.44000
(-5.43%)
7.67000 USD
N
NNDM
-0.07500
(-3.10%)
2.34500 USD
T
TDOC
-0.85000
(-9.00%)
8.59000 USD
News

Title: Bionano Genomics

Sector: Healthcare
Industry: Medical Instruments & Supplies
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.